中证香港100医药卫生指数

Search documents
中证香港100医药卫生指数报1132.15点,前十大权重包含药明生物等
Jin Rong Jie· 2025-08-14 07:54
Group 1 - The core viewpoint of the article highlights the significant performance of the China Securities Hong Kong 100 Healthcare Index, which has seen a remarkable increase of 21.00% in the past month, 52.68% in the past three months, and 95.84% year-to-date [1] - The index is categorized based on the China Securities industry classification standards, with a base date of December 31, 2004, and a base point of 1000.0 [1] - The index is fully composed of securities listed on the Hong Kong Stock Exchange, with the chemical drugs sector accounting for 54.75%, biopharmaceuticals for 18.73%, pharmaceutical and biotechnology services for 14.45%, and medical commerce and services for 12.07% [1] Group 2 - The index samples are adjusted biannually, specifically on the next trading day following the second Friday of June and December [2] - Weight factors are generally fixed until the next scheduled adjustment, with provisions for temporary adjustments under special circumstances [2] - Adjustments to the index samples occur in response to changes in the parent index, special events affecting industry classification, or the delisting of sample companies [2]
中证香港100医药卫生指数报1095.17点,前十大权重包含石药集团等
Jin Rong Jie· 2025-08-08 07:47
资料显示,指数样本每半年调整一次,样本调整实施时间分别为每年6月和12月的第二个星期五的下一 交易日。权重因子随样本定期调整而调整,调整时间与指数样本定期调整实施时间相同。在下一个定期 调整日前,权重因子一般固定不变。特殊情况下将对指数进行临时调整。当对应的母指数调整样本时, 行业指数样本将相应调整。当样本公司有特殊事件发生,导致其行业归属发生变更时,将对指数进行相 应调整。当样本退市时,将其从指数样本中剔除。样本公司发生收购、合并、分拆等情形的处理,参照 计算与维护细则处理。 本文源自:金融界 数据统计显示,中证香港100医药卫生指数近一个月上涨20.84%,近三个月上涨44.95%,年至今上涨 89.44%。 据了解,中证香港100行业指数系列将中证香港100指数样本按中证行业分类标准进行分类,再以各自行 业全部证券作为对应行业指数的样本。该指数以2004年12月31日为基日,以1000.0点为基点。 从中证香港100医药卫生指数持仓的市场板块来看,香港证券交易所占比100.00%。 从中证香港100医药卫生指数持仓样本的行业来看,化学药占比55.11%、生物药品占比18.62%、制药与 生物科技服务占比 ...
中证香港100医药卫生指数报1134.87点,前十大权重包含药明生物等
Jin Rong Jie· 2025-08-06 07:44
金融界8月6日消息,上证指数低开高走,中证香港100医药卫生指数 (H100医药,L11185)报1134.87点。 数据统计显示,中证香港100医药卫生指数近一个月上涨22.21%,近三个月上涨41.09%,年至今上涨 96.31%。 据了解,中证香港100行业指数系列将中证香港100指数样本按中证行业分类标准进行分类,再以各自行 业全部证券作为对应行业指数的样本。该指数以2004年12月31日为基日,以1000.0点为基点。 从中证香港100医药卫生指数持仓的市场板块来看,香港证券交易所占比100.00%。 从中证香港100医药卫生指数持仓样本的行业来看,化学药占比54.47%、生物药品占比19.42%、制药与 生物科技服务占比14.91%、医疗商业与服务占比11.20%。 资料显示,指数样本每半年调整一次,样本调整实施时间分别为每年6月和12月的第二个星期五的下一 交易日。权重因子随样本定期调整而调整,调整时间与指数样本定期调整实施时间相同。在下一个定期 调整日前,权重因子一般固定不变。特殊情况下将对指数进行临时调整。当对应的母指数调整样本时, 行业指数样本将相应调整。当样本公司有特殊事件发生,导致其行 ...
中证香港100医药卫生指数报1100.25点,前十大权重包含信达生物等
Jin Rong Jie· 2025-08-05 07:41
Group 1 - The core viewpoint of the news is that the China Securities Hong Kong 100 Pharmaceutical and Health Index has shown significant growth, with a year-to-date increase of 90.32% [1] - The index has risen by 18.48% in the past month and 36.79% in the last three months, indicating strong performance in the pharmaceutical sector [1] - The index is composed entirely of securities listed on the Hong Kong Stock Exchange, with a base date of December 31, 2004, and a base point of 1000.0 [1] Group 2 - The index sample is adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2] - Weight factors are generally fixed until the next scheduled adjustment, but can be temporarily modified under special circumstances [2] - Adjustments to the index sample occur in response to events such as delistings, mergers, or changes in industry classification [2]